NL7407176A - - Google Patents

Info

Publication number
NL7407176A
NL7407176A NL7407176A NL7407176A NL7407176A NL 7407176 A NL7407176 A NL 7407176A NL 7407176 A NL7407176 A NL 7407176A NL 7407176 A NL7407176 A NL 7407176A NL 7407176 A NL7407176 A NL 7407176A
Authority
NL
Netherlands
Application number
NL7407176A
Other versions
NL163221B (nl
NL163221C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7407176A publication Critical patent/NL7407176A/xx
Publication of NL163221B publication Critical patent/NL163221B/xx
Application granted granted Critical
Publication of NL163221C publication Critical patent/NL163221C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7407176.A 1973-05-30 1974-05-29 Werkwijze voor het bereiden van een farmaceutisch preparaat met onstekingsgenezende werking, onder toe- passing daarvan verkregen gevormd preparaat, en werk- wijze voor het bereiden van een 21-mercaptosteroid geschikt voor toepassing bij voornoemde werkwijze. NL163221C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7319734A FR2231374B1 (fr) 1973-05-30 1973-05-30

Publications (3)

Publication Number Publication Date
NL7407176A true NL7407176A (fr) 1974-12-03
NL163221B NL163221B (nl) 1980-03-17
NL163221C NL163221C (nl) 1980-08-15

Family

ID=9120281

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7407176.A NL163221C (nl) 1973-05-30 1974-05-29 Werkwijze voor het bereiden van een farmaceutisch preparaat met onstekingsgenezende werking, onder toe- passing daarvan verkregen gevormd preparaat, en werk- wijze voor het bereiden van een 21-mercaptosteroid geschikt voor toepassing bij voornoemde werkwijze.

Country Status (7)

Country Link
US (1) US4014909A (fr)
JP (1) JPS5136273B2 (fr)
BE (1) BE815590A (fr)
CA (1) CA1041083A (fr)
FR (1) FR2231374B1 (fr)
GB (1) GB1475795A (fr)
NL (1) NL163221C (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144070Y2 (fr) * 1978-05-15 1986-12-12
FR2442856A1 (fr) * 1978-12-01 1980-06-27 Sipsy Procede de preparation de steroides
US4262940A (en) * 1978-12-15 1981-04-21 The Johnson Corporation Internally compensated self-aligning rotary joint
FR2529894B2 (fr) * 1981-07-30 1986-07-25 Jouveinal Steroides esterifies en la position 17 et thio-esterifies en la position 21 et leur application comme medicament
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
FR2551069B1 (fr) * 1983-08-26 1986-07-25 Jouveinal Sa 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament
JPS6175974U (fr) * 1984-10-24 1986-05-22
US4861765A (en) * 1985-06-26 1989-08-29 Jouveinal 21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
US5116829A (en) * 1990-04-23 1992-05-26 Kao Corporation Steroid compounds
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5602094A (en) * 1994-03-29 1997-02-11 Goddard; David Treatment of tumors
IES960231A2 (en) * 1996-03-20 1996-07-24 Losbanos Ltd Manufacture of steroids
WO2001040805A1 (fr) * 1999-11-30 2001-06-07 Akzo Nobel N.V. Composes steroidiques destines a des dosages par liaison de recepteur de steroides
NZ545748A (en) * 2003-08-29 2010-03-26 Ranbaxy Lab Ltd Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
WO2005051931A2 (fr) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
MX2009003100A (es) * 2006-09-22 2009-05-11 Ranbaxy Lab Ltd Inhibidores de fosfodiesterasa tipo iv.
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
EP2124943A1 (fr) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
CN102099368A (zh) * 2007-12-21 2011-06-15 先灵公司 作为糖皮质激素受体激动剂的c-21硫醚
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
PL3153502T4 (pl) * 2013-09-25 2019-07-31 H4 Pharma Sposób syntezy soli mineralnej kwasu pivalicznego jako produkt pośredni

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2814632A (en) * 1957-02-21 1957-11-26 Schering Corp Steroid compounds and methods for their manufacture
FR1187M (fr) * 1961-03-17 1962-03-19 Roussel Uclaf Nouveau médicament notamment pour le traitement des manifestations inflammatoires d'origine rhumatismale arthritique ou infectieuse.
DE2044831A1 (fr) * 1969-09-18 1971-03-25
CH566349A5 (fr) * 1969-12-24 1975-09-15 Ciba Geigy Ag
US3803133A (en) * 1972-12-15 1974-04-09 Squibb & Sons Inc 21-sulfinyl steroids

Also Published As

Publication number Publication date
US4014909A (en) 1977-03-29
CA1041083A (fr) 1978-10-24
JPS5030863A (fr) 1975-03-27
NL163221B (nl) 1980-03-17
FR2231374B1 (fr) 1976-10-22
NL163221C (nl) 1980-08-15
BE815590A (fr) 1974-09-16
DE2357778B2 (de) 1977-02-17
FR2231374A1 (fr) 1974-12-27
GB1475795A (en) 1977-06-10
DE2357778A1 (de) 1974-12-19
JPS5136273B2 (fr) 1976-10-07

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
FR2231374B1 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU471461B2 (fr)
AU477824B2 (fr)
JPS5411656Y2 (fr)
AR196123Q (fr)
AU479521A (fr)
AU479404A (fr)
AU479562A (fr)
AU479539A (fr)
AU479522A (fr)
BG18636A1 (fr)
AU479504A (fr)
AU479496A (fr)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent